medigraphic.com
ISSN 1527-3172 (Electronic)

2016, Number 1-2

<< Back Next >>

MEDICC Review 2016; 18 (1-2)

Prevalence of metabolic syndrome risk factors in adults in Holguín, Cuba (2004−2013)

Miguel-Soca PE, Rivas-Estévez M, Sarmiento-Teruel Y, Mariño-Soler AL, Marrero-Hidalgo M, Mosqueda-Batista L, Peña-Pérez I, Rivas-Vázquez D, Llorente-Columbié Y

Language: English
References: 48
Page: 28-33
PDF size: 322.34 Kb.


ABSTRACT

Introduction High prevalence of metabolic syndrome and its associated risk factors in adults represents both a Cuban and a worldwide public health problem.
Objective Determine prevalence of metabolic syndrome’s component risk factors in a representative sample of adults in Holguín Province, Cuba.
Methods A cross-sectional study was conducted using multistage probability sampling of four Holguín Province municipalities: Holguín, Gibara, Urbano Noris and Banes. We selected a sample of 2085 patients aged ≥20 years during 2004–2013 and measured clinical, anthropometric and biochemical variables. Risk factor prevalence rates were calculated using EPIDAT 3.1.
Results Crude metabolic syndrome prevalence rate was 27.2% (CI 25.3%–29.1%). Crude prevalence rates (with 95% CI) of risk factors were as follows: hypertriglyceridemia 36.1% (34.0%–38.2%); hypercholesterolemia 25.5% (23.6%–27.4%); low HDL cholesterol 26.3% (24.4%–28.2%); high LDL cholesterol 10.1% (8.8%–11.4%); prediabetes 2.2% (1.6%–2.8%); diabetes 14.6% (13.1%–16.1%); prehypertension 3.5% (2.7%–4.3%); hypertension 34.5% (32.5%–36.5%); overweight 23.4% (21.6%–25.2%); obesity 32.0% (30.0%–34.0%) and central obesity 47.3% (45.2%–49.4%). They were significantly higher in women and older adults.
Conclusions High prevalence of risk factors associated with metabolic syndrome confirms the magnitude of this health problem, particularly in women and older adults.


REFERENCES

  1. Varona P, Bonet M, García R, Chang M, Ramón Suárez R. Implementation of chronic disease risk factor surveillance in 12 Cuban municipalities. MEDICC Rev. 2014 Jan;16(1):43–7.

  2. World Health Organization. Preventing chronic diseases: a vital investment: WHO global report. Geneva: World Health Organization; 2005. 200 p.

  3. Pan American Health Organization. Enfermedades no transmisibles en las Américas: construyamos un futuro más saludable. Washington, D.C.: Pan American Health Organization; 2011. Spanish.

  4. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association. Defi nition of Metabolic Syndrome. Circulation [Internet]. 2004 Jan 27 [cited 2016 Mar 15];109:433–8. Available from: http://circ .ahajournals.org/content/109/3/433.short

  5. Ferrante D, Linetzky B, Konofi no J, King A, Virgolini M, Laspiur S. Encuesta Nacional de Factores de Riesgo 2009: evolución de la epidemia de enfermedades crónicas no transmisibles en Argentina. Estudio de corte transversal. Rev Argent Salud Pública. 2011 Mar;2(6):34–41. Spanish.

  6. World Health Organization. Facts related to chronic diseases. Geneva: World Health Organization; c2013 [cited 2006 Jan 20]. Available from: http://www.who.int/topics/chronic_diseases/fact sheets/en/index.html

  7. Miguel Soca PE, Niño Escofet S, Rodríguez López M, Almaguer Herrera A. Pesquisaje de síndrome metabólico en mujeres obesas. Correo Científi co Médico Holguín [Internet]. 2004 [cited 2013 Oct 13]; [about 4 screens]. Available from: http://www.cocmed.sld.cu/no84/n84ori5.htm. Spanish.

  8. Hernández Tamayo M, Miguel Soca PE, Marrero Hidalgo MM, Pérez López LM, Peña Pérez I, Rivas Estévez M. Comportamiento de variables clínicas, antropométricas y de laboratorio en pacientes con síndrome metabólico. Medisur [Internet]. 2011 Mar–Apr [cited 2013 Sep 15];9(2). Available from: http://medisur.sld.cu/ index.php/medisur/article/view/1260/716. Spanish.

  9. Hernández Tamayo M, Miguel Soca PE, Marrero Hidalgo M, Rodríguez Graña T, Niño Escofet S. Caracterización del síndrome metabólico en pacientes adultos con obesidad. MEDISAN [Internet]. 2012 Mar [cited 2014 Jan 9];16(3):341–8. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid =S1029-30192012000300005. Spanish.

  10. National Statistics Bureau (CU). Anuario Estadístico de Cuba 2013 [Internet]. [cited 2014 May 12]. Havana: National Statistics Bureau (CU). Available from: http://www.one.cu/aec2013/esp /20080618_tabla_cuadro.htm. Spanish.

  11. Lwanga SK, Lemeshow S. Sample size determination in health studies. Geneva: World Health Organization; 1991. 22 p.

  12. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499–502.

  13. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final Report. Circulation. 2002 Dec 17;106:3143–421.

  14. American Diabetes Association. Diagnosis and Classifi cation of Diabetes Mellitus. Diabetes Care. 2012;35(Suppl 1):S64–71.

  15. Comisión Nacional Técnica Asesora del Programa de Hipertensión arterial. Hipertensión arterial. Guía para la prevención, diagnóstico y tratamiento. Havana: Editorial Ciencias Médicas; 2008. Spanish.

  16. Ward BW, Schiller JS. Prevalence of multiple chronic conditions among US adults: estimates from the National Health Interview Survey, 2010. Prev Chronic Dis [Internet]. 2013 Apr [cited 2014 Jan 12];10:E65. DOI: 10:120203. Available from: http://www.cdc.gov/pcd/issues/2013/12_0203 .htm

  17. Ayanian JZ, Zaslavsky AM, Weissman JS, Schneider EC, Ginsburg JA. Undiagnosed hypertension and hypercholesterolemia among uninsured and insured adults in the Third National Health and Nutrition Examination Survey. Am J Public Health. 2003 Dec;93(12):2051–4.

  18. Naranjo AA, Rodríguez ÁY, Llera RE, Aroche R. Diabetes risk in a Cuban primary care setting in persons with no known glucose abnormalities. MEDICC Rev. 2013 Apr;15(2):16–9.

  19. Valdés Ramos E, Bencosme Rodríguez N. Síndrome metabólico y enfermedad cardiovascular en personas con diabetes mellitus tipo 2. Rev CubanaEndocrinol [Internet]. 2013 May–Aug [cited 2013 Dec 13];24(2):125–35. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext &pid=S1561-29532013000200003&lng=es. Spanish.

  20. Agramonte Martínez M, Barnés Dominguez JA, Pinto Correa MÁ. Prevalencia del síndrome metabólico en pacientes diabéticos tipo 2. Rev Cubana Med [Internet]. 2009 [cited 2014 Jan 8];48(1). Available from: http://scielo.sld .cu/scielo.php?script=sci_arttext&pid=S0034 -75232009000100002&lng=es. Spanish.

  21. Bustillo Solano EE, Bustillo Madrigal EE, Pérez Francisco Y, Pérez Sosa R, Brito García Á, González Iglesia Á, et al. Prevalencia de la diabetes mellitus y de la glucemia alterada en ayunas en un área de la ciudad de Sancti Spíritus. Rev Cubana Endocrinol [Internet]. 2013 May–Aug [cited 2013 Oct 10];24(2):107–24. Available from: http://scielo .sld.cu/scielo.php?script=sci_arttext&pid=S1561 -29532013000200002&lng=es. Spanish.

  22. Díaz ME, Jiménez S, García RG, Bonet M, Wong I. Overweight, obesity, central adiposity and associated chronic diseases in Cuban adults. MEDICC Rev. 2009 Apr;11(4):23–8.

  23. Valdés Pacheco E, Morrees Abella A, Alonso Díaz NL. Prevalencia y factores de riesgo de cardiopatía isquémica. Rev Cubana Med Gen Integr [Internet]. 1998 [cited 2013 Sep 10];14(6):590–4. Available from: http://scielo .sld.cu/scielo.php?script=sci_arttext&pid=S0864 -21251998000600014&lng=es. Spanish.

  24. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics association 2014 update: a report from the American Heart Association. Circulation. 2014 Jan 21;129(3):e28–e292.

  25. Sherpa LY, Deji, Stigum H, Chongsuvivatwong V, Nafstad P, Bjertness E. Prevalence of metabolic syndrome and common metabolic components in high altitude farmers and herdsmen at 3700 m in Tibet. High Alt Med Biol. 2013 Mar;14(1):37–44.

  26. Deng B, Luo T, Huang Y, Shen T, Ma J. Prevalence and determinants of hyperlipidemia in moderate altitude areas of the Yunnan-Kweichow Plateau in Southwestern China. High Alt Med Biol. 2012 Mar;13(1):13–21.

  27. Hou X, Liu Y, Lu H, Ma X, Hu C, Bao Y, et al. Ten-year changes in the prevalence of overweight, obesity and central obesity among the Chinese adults in urban Shanghai, 1998–2007 —comparison of two cross-sectional surveys. BMC Public Health [Internet]. 2013 Nov 12 [cited 2014 Jan 19];13:1064. Available from: http://www .biomedcentral.com/1471-2458/13/1064

  28. Tanaka S, Takase H, Dohi Y, Kimura G. The prevalence and characteristics of microalbuminuria in the general population: a cross-sectional study. BMC Research Notes [Internet]. 2013 Jul 7 [cited 2014 Jan 9];6:256. DOI: 10.1186/1756-0500-6- 256. Available from: http://www.biomedcentral .com/1756-0500/6/256

  29. Guallar-Castillón P, Gil-Montero M, León-Muñoz LM, Graciani A, Bayán-Bravo A, Taboada JM, et al. Magnitud y manejo de la hipercolesterolemia en la población adulta de España, 2008– 2010: el estudio ENRICA. Rev Esp Cardiol. 2012;65(6):551–8. Spanish.

  30. Meaney A, Ceballos-Reyes G, GutiérrezSalmean G, Samaniego-Méndez V, Vela-Huerta A, Alcocer L, et al. Cardiovascular risk factors in a Mexican middle-class urban population. The Lindavista Study. Arch Cardiol Mex. 2013 Oct– Dec;83(4):249–56.

  31. Al Zenki S, Al Omirah H, Al Hooti S, Al Hamad N, Jackson RT, Rao A, et al. High prevalence of metabolic syndrome among Kuwaiti adults—a wakeup call for public health intervention. Int J Environ Res Public Health. 2012 May;9(5):1984–96.

  32. Ferguson TS, Tulloch-Reid MK, Younger NO, Knight-Madden JM, Samms-Vaughan M, Ashley D, et al. Prevalence of the metabolic syndrome and its components in relation to socioeconomic status among Jamaican young adults: a crosssectional study. BMC Public Health [Internet]. 2010 Jun 3 [cited 2013 Dec 28];10:307. DOI: 10.1186/1471-2458-10-307. Available from: http://www.biomedcentral.com/1471-2458/10/ 307

  33. Chen CM, Yeh MC. The prevalence and determinants of impaired fasting glucose in the population of Taiwan. BMC Public Health [Internet]. 2013 Dec 5 [cited 2013 Dec 29];13:1123. DOI: 10.1186/1471-2458-13-1123. Available from: http://www.biomedcentral.com/1471-2458/13/ 1123

  34. Kotwani P, Kwarisiima D, Clark TD, Kabami J, Geng EH, Jain V, et al. Epidemiology and awareness of hypertension in a rural Ugandan community: a cross-sectional study. BMC Public Health [Internet]. 2013 Dec 9 [cited 2013 Dec 28];13:1151. DOI: 10.1186/1471-2458-13- 1151. Available from: http://www.biomedcentral .com/1471-2458/13/1151

  35. Capingana DP, Magalhães P, Silva AB, Gon- çalves MA, Baldo MP, Rodrigues SL, et al. Prevalence of cardiovascular risk factors and socioeconomic level among public-sector workers in Angola. BMC Public Health [Internet]. 2013 [cited 2013 Dec 28];13:732. Available from: http://www.biomedcentral.com/1471-2458/13/ 732

  36. Pan L, Song YS, Ma R, Ye XD, Liao YH. [An epidemiology study on hypertension in the Zhuang nationality village from the Guangxi Zhuang autonomous region]. Zhonghua Xin Xue Guan Bing Za Zhi. 2013 Sep;41(9):790–4. Chinese.

  37. Ballesteros Hernández M, Guirado Blanco O. Los estrógenos como protectores cardiovasculares. Medicentro Electrón [Internet]. 2012 Jul–Sep [cited 2013 Nov 11];16(3):148–53. Available from: http://www.medicentro.sld.cu/index.php/medi centro/article/view/1273/1197

  38. Lee MH, Kim HC, Ahn SV, Hur NW, Choi DP, Park CG, et al. Prevalence of dyslipidemia among Korean adults: Korea National Health and Nutrition Survey 1998-2005. Diabetes Metab J. 2012 Feb;36(1):43–55.

  39. Prasad DS, Kabir Z, Dash AK, Das BC. Prevalence and risk factors for metabolic syndrome in Asian Indians: a community study from urban Eastern India. J Cardiovasc Dis Res. 2012 Jul;3(3):204–11.

  40. Miguel-Soca P, Cruz-Lage L, Edwards-Scringer I. Genes de la obesidad monogénica. An Sist Sanit Navar. 2013 Jan–Apr;36(1):125–7. Spanish.

  41. Majeed A, El-Sayed AA, Khoja T, Alshamsan R, Millett C, Rawaf S. Diabetes in the MiddleEast and North Africa: an update for 2013 for the IDF Diabetes Atlas. Diabetes Res Clin Pract [Internet]. 2013 Dec [cited 2014 Jan 29]. Epub ahead of print. Available from: http://dx.doi .org/10.1016/j.diabres.2013.11.00826

  42. National Health Statistics and Medical Records Division (CU). Anuario Estadístico 2013. Havana: Ministry of Public Health (CU). Available from: http://bvscuba.sld.cu/anuario-estadistico -de-cuba. 189 p. Spanish.

  43. Tamayo T, Rosenbauer J, Wild SH, Spijkerman AMW, Baan C, Forouhi NG, et al. Diabetes in Europe: an update for 2013 for the IDF Diabetes Atlas. Diabetes Res Clin Pract [Internet]. 2013 Dec 3 [cited 2014 Jan 19]. Available from: http:// dx.doi.org/10.1016/j.diabres.2013.11.007

  44. Bonet Gorbea M, Varona Pérez P. III Encuesta Nacional de factores de riesgo y actividades preventivas de enfermedades no transmisibles. Cuba 2010-2011. Havana: Editorial de Ciencias Médicas; 2014. Spanish.

  45. Pérez CM, Sánchez H, Ortiz AP. Prevalence of overweight and obesity and their cardiometabolic comorbidities in Hispanic adults living in Puerto Rico. J Community Health. 2013 Dec;38(6):1140–6.

  46. Rodríguez-Rodríguez E, López-Plaza B, López-Sobaler AM, Ortega RM. Prevalencia de sobrepeso y obesidad en adultos espa- ñoles. Nutr Hosp. 2011 Mar–Apr;26(2):355– 63. Spanish.

  47. National Cancer Intelligence Network (UK). One, Five and Ten Year Cancer Prevalence by Cancer Network, UK, 2006 [Internet]. London: NCIN; 2009 [cited 2016 Mar 6]. Available from: http:// www.ncin.org.uk/view?rid=76

  48. Ward MM. Estimating disease prevalence and incidence using administrative data: some assembly required. J Rheumatol. 2013 Aug; 40(8):1241–3. DOI:10.3899/jrheum.130675




2020     |     www.medigraphic.com